Boulder Community Hospital was a non-profit hospital located in Boulder, Colorado and operated from 1926 to 2019.

During the past decade, Boulder Community Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 149 clinical trials were completed, i.e. on average, 219.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 53 clinical trials were completed. i.e. 1325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boulder Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "Alliance for Clinical Trials in Oncology" with 62 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "Eastern Cooperative Oncology Group" with 21 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boulder Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 163 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Boulder Community Hospital" are "Breast Cancer" (25 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (13 trials), "Lung Cancer" (10 trials) and "Recurrent Breast Carcinoma" (10 trials). Many other conditions were trialed in "Boulder Community Hospital" in a lesser frequency.

Most popular intervention types in "Boulder Community Hospital" are "Drug" (230 trials), "Other" (161 trials), "Biological" (124 trials), "Procedure" (46 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (84 trials), "Quality-of-Life Assessment" (51 trials), "Paclitaxel" (29 trials), "placebo" (29 trials) and "Bevacizumab" (25 trials). Other intervention names were less common.

The vast majority of trials in "Boulder Community Hospital" are 219 trials for "All" genders, 49 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Boulder Community Hospital". undefined are not yet recruiting, 20 are recruiting, 105 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 126 completed trials in Boulder Community Hospital, 3 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Boulder Community Hospital, 5 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Boulder Community Hospital has several departments that took part in Clinical trials: "Beacon Clinic at Boulder CRS" - 8 trials, "Associated Neurologists, PC" - 2 trials